Report cover image

Novel Autism Diagnostics

Published Feb 05, 2016
Length 103 Pages
SKU # KLI5876130

Description

Novel Autism Diagnostics

Novel Autism Diagnostics reviews selected autism test innovations, summarizing many of the current approaches to autism diagnostics, which include molecular testing, pre-disposition screening, targeted sequencing-based testing, next-generation sequencing with modeling, genetic risk assessment / testing, cloud platform approaches, microarrays, end-to-end sequencing, gene variants, and blood-based genetic testing. The report looks at the companies behind these testing approaches as well. Asuragen, Google Genomics, Illumina, and LabCorp are among the companies discussed within the report’s competitive analysis.

Table of Contents

103 Pages
    • OVERVIEW OF ASD
    • LEADING COMPETITORS
    • METHODOLOGY
    • OVERVIEW OF AUTISM
    • SCREENING AND DIAGNOSIS
    • EMERGING DIAGNOSTICS
    • POTENTIAL MARKET
    • RESEARCH
    • AMBRY GENETICS CORP.
    • ARUP LABORATORIES
    • ASURAGEN INC.
    • ATHENA DIAGNOSTICS, INC. (AQUEST DIAGNOSTICS BUSINESS)
    • CLARITAS GENOMICS, INC.
    • COMBIMATRIX CORP.
    • COURTAGEN LIFE SCIENCES, INC.
    • EMORY GENETICS LABORATORY
    • GENEPEEKS, INC.
    • GENOMA SA (A SUBSIDIARY OF THE ESPERITE GROUP)
    • GOOGLE GENOMICS
    • GREENWOOD GENETIC CENTER
    • ILLUMINA
    • INTEGRAGEN
    • LABCORP, LABORATORY CORPORATION OF AMERICA
    • LIFE TECHNOLOGIES CORPORATION
    • LINEAGEN, INC.
    • MEDOMICS, LLC
    • POPULATION DIAGNOSTICS
    • RAINDANCE TECHNOLOGIES, INC.
    • SYNAPDX CORPORATION
    • TRANSGENOMIC, INC.
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.